Stroke in Pregnancy

  • Steven K. FeskeEmail author


Pregnancy confers an increased risk of both ischemic and hemorrhagic stroke, and, though uncommon, pregnancy-associated stroke is an important cause of long-term disability in young women. This chapter begins with a brief review of the physiologic and pathophysiologic features of pregnancy that contribute to stroke risk and the epidemiology of different types of stroke in pregnancy. It then moves to diagnosis and therapy. Because physicians who do not routinely treat pregnant women may shy away from decision-making due to concern for risk, it is important to emphasize the options for rapid imaging diagnosis during pregnancy. Stroke therapies have expanded greatly in recent years, and their applications demands rapid action. To provide pregnant women with the fullest opportunity to benefit from such advances, it is critical that physicians be aware of the potential therapies and their availability during pregnancy and the puerperium.


Pregnancy-associated stroke Ischemic stroke Cerebral hemorrhage Cerebral venous sinus thrombosis Pregnancy Preeclampsia-eclampsia 


  1. 1.
    Feske SK, Klein AM. Neurology of pregnancy and the puerperium. In: Schapira A, editor. Neurology and clinical neuroscience. 1st ed. Philadelphia: Mosby Elsevier; 2007. p. 1490–503.Google Scholar
  2. 2.
    Feske SK, Singhal A. Cerebrovascular disorders complicating pregnancy. Continuum. 2014;20:80–99.PubMedGoogle Scholar
  3. 3.
    Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S, and coagulation in normal pregnancy. Thromb Haemost. 1998;79:1166–70.CrossRefGoogle Scholar
  4. 4.
    Wickström K, Edelstam G, Löwbeer CH, Hansson LO, Sieghahn A. Reference intervals for plasma levels of fibrinogen, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004;64:31–40.CrossRefGoogle Scholar
  5. 5.
    Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MSV. Risk of thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–15.CrossRefGoogle Scholar
  6. 6.
    Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecokl Reprod Biol. 1997;73:31–6.CrossRefGoogle Scholar
  7. 7.
    Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768–74.CrossRefGoogle Scholar
  8. 8.
    Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke. 1997;28:280–3.CrossRefGoogle Scholar
  9. 9.
    Ban L, Sprigg N, Abdul Sultan A, et al. Incidence of first stroke in pregnant and nonpregnant women of childbearing age: a population-based cohort study from England. J Am Heart Assoc. 2017;6:e004601.CrossRefGoogle Scholar
  10. 10.
    Sharshar T, Lamy C, Mas JL, Stroke in Pregnancy Study Group. Incidence and causes of strokes associated with pregnancy and puerperium: a study in public hospitals of Ile de France. Stroke. 1995;26:930–6.CrossRefGoogle Scholar
  11. 11.
    Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy adn puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18:290–5.CrossRefGoogle Scholar
  12. 12.
    Kuklina EV, Tong X, Bansil P, George MG, Callaghan WM. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke. 2011;42:2564–70.CrossRefGoogle Scholar
  13. 13.
    Chansakul T, Young GS. Neuroimaging in pregnant women. Semin Neurol. 2017;37:712–23.CrossRefGoogle Scholar
  14. 14.
    Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46.CrossRefGoogle Scholar
  15. 15.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1996;333:1581–7.Google Scholar
  16. 16.
    Hacke W, Kaste M, Bluhmki E, ECASS Investigators, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.CrossRefGoogle Scholar
  17. 17.
    Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.CrossRefGoogle Scholar
  18. 18.
    Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.CrossRefGoogle Scholar
  19. 19.
    Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.CrossRefGoogle Scholar
  20. 20.
    Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.CrossRefGoogle Scholar
  21. 21.
    Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.CrossRefGoogle Scholar
  22. 22.
    Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15:1138–47.CrossRefGoogle Scholar
  23. 23.
    Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.CrossRefGoogle Scholar
  24. 24.
    Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.CrossRefGoogle Scholar
  25. 25.
    Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–90.CrossRefGoogle Scholar
  26. 26.
    The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995;345:1455–63.CrossRefGoogle Scholar
  27. 27.
    Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201–5.CrossRefGoogle Scholar
  28. 28.
    Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990;27:855–65, discussion 865–856.CrossRefGoogle Scholar
  29. 29.
    Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venus thrombosis. Lancet. 1991;338:597–600.CrossRefGoogle Scholar
  30. 30.
    de Bruijn SFTM, Starn J, for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484–8.CrossRefGoogle Scholar
  31. 31.
    Lamy C, Hamon JB, Coste J, Mas JL. Iachemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology. 2000;55:269–74.CrossRefGoogle Scholar
  32. 32.
    CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343:619–29.CrossRefGoogle Scholar
  33. 33.
    Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth retardation with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14.CrossRefGoogle Scholar
  34. 34.
    Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators I. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.CrossRefGoogle Scholar
  35. 35.
    Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.CrossRefGoogle Scholar
  36. 36.
    Dentali F, Poli D, Sconditti U, CErebral VEin Thrombosis International Study Investigators, et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study [published correction appears in J Thromb Haemost 2013;11:3991]. J Thromb Haemost. 2012;10:1297–302.CrossRefGoogle Scholar
  37. 37.
    Saposnik G, Barinagarrementeria F, Brown RD, American Heart Association Stroke Council and the Council on Epidemiology and Prevention, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.CrossRefGoogle Scholar
  38. 38.
    Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis. 2002;13:290.CrossRefGoogle Scholar
  39. 39.
    Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke. 2006;37:2168–9.CrossRefGoogle Scholar
  40. 40.
    Leonhardt G, Gaul C, Nietsch HH, Buerke M. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21:271–6.CrossRefGoogle Scholar
  41. 41.
    Murugappan A, Coplin WM, Al-Sadat AN, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology. 2006;66:768–70.CrossRefGoogle Scholar
  42. 42.
    Yamaguchi Y, Kondo T, Ihara M, et al. Intravenous recombinant tissue plasminogen activator in an 18-weeks pregnant woman with embolic stroke. Clin Neurol. 2010;50:315–9.Google Scholar
  43. 43.
    Hori H, Yamamoto F, Ito Y, Hashimoto Y, Hirano T, Uchino M. Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency. Rinsho Shinkeigaku. 2013;53:212–6.CrossRefGoogle Scholar
  44. 44.
    Tassi R, Acampa M, Marotta G, et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med. 2013;31:448e441–3.Google Scholar
  45. 45.
    Ritter LM, Schüler A, Gangopadhyay R, et al. Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol. 2014;26:632–4.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Harvard Medical School, Division of Stroke and Cerebrovascular Disease, Neurology DepartmentBrigham and Women’s HospitalBostonUSA

Personalised recommendations